Longtime Myriad Genetics (NASDAQ: MYGN) president and CEO Mark Capone has resigned. The Salt Lake City-based molecular diagnostic company said Myriad and Capone—who has been with the company for 17 years—mutually agreed it was the right time for a leadership transition.
Bryan Riggsbee, Myriad’s chief financial officer, was appointed interim president and CEO. He will continue to serve as CFO, too, as Myriad searches for a permanent CEO. Riggsbee, who joined Myriad in October 2014, most recently served as senior vice president of corporate finance at LabCorp (NYSE: LH).
UNDERWRITERS AND PARTNERS